how many people are on glp-1 drugs in the us Chart: 1 8 Americans Now Use for Weight Loss US households with GLP-1 users

Back Patchen, T (8 March 2024) 'FDA approves novo's obesity drug Wegovy to reduce cardiovascular events', Biospace

Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic Review

Notably, the deal comes as AbbVie looks for its next top-selling drug following the patent expiration for its mega blockbuster autoimmune medicine Humira

[DOI] [PubMed] [Google Scholar] 153.Fox C.K., Marlatt K.L., Rudser K.D., Kelly A.S

"GLP-1 medications are powerful tools, but they are not passive treatments, and patients who combine them with proper nutrition, strength training and medical oversight are more likely to achieve healthier and more sustainable outcomes," she said.

2022 AHA/ACC/HFSA guideline for the management of heart failure: Executive summary: A report of the American college of cardiology/American heart association joint committee on clinical practice guidelines